Table 4.
Contingency table demonstrating implications of potential RCT outcomes
| Potential HIV incidence outcome | Other potential results | Impact on programmes policy in high HIV prevalence regions | Programmatically relevant data from study | |
| Hypothesis proved | Targeted better. | Fewer women on PrEP, cost-effective and safe. | Implement targeted PrEP. | Data to model and compare impact on HIV transmission, cost and scale up. HIV incidence/CI, cost-effectiveness, safety, feasibility and process. |
| Hypothesis opposed | Universal better. | Fewer women on PrEP, cost-effective and safe. | Implement universal PrEP. | |
| Mixed benefits | Universal better. | Universal too many women on PrEP not cost effective. | Refine universal strategy to decrease cost and unnecessary PrEP exposure. | |
| Mixed findings | Incidence low in both, no difference. | Targeted more cost-effective results in few on PrEP. | Implement targeted PrEP. | HIV incidence estimate/CI, cost-effectiveness, safety and process. |
| Universal more cost-effective and fewer women on PrEP. | Implement universal PrEP. |
PrEP, pre-exposure prophylaxis.